Literature DB >> 16402108

Antiarrhythmic drug research.

M J A Walker1.   

Abstract

This article was written as part of the 75th anniversary celebration of the British Pharmacological Society (BPS). It discusses antiarrhythmic drug research conducted by members of BPS, and as published in the British Journal of Pharmacology (BJP). BPS members, past and present, as well as antiarrhythmic manuscripts published in the BJP have been identified. From these data, the article attempts to semiquantitatively summarize results published in the journal, but only quotes selected manuscripts and individuals. Apologies are offered for omissions and errors, but as in any history, a writer's biases and opinions are unavoidable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402108      PMCID: PMC1760742          DOI: 10.1038/sj.bjp.0706500

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents.

Authors:  M Longobardo; T González; R Navarro-Polanco; R Caballero; E Delpón; J Tamargo; D J Snyders; M M Tamkun; C Valenzuela
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone.

Authors:  A Varró; J Takács; M Németh; O Hála; L Virág; N Iost; B Baláti; M Agoston; A Vereckei; G Pastor; M Delbruyère; P Gautier; D Nisato; J G Papp
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.

Authors:  Andrew J Batey; Susan J Coker
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.

Authors:  Péter Biliczki; László Virág; Norbert Iost; Julius Gy Papp; András Varró
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.

Authors:  James T Milnes; Olivia Crociani; Annarosa Arcangeli; Jules C Hancox; Harry J Witchel
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.

Authors:  Ricardo Caballero; Marc Pourrier; Gernot Schram; Eva Delpón; Juan Tamargo; Stanley Nattel
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.

Authors:  Csaba Lengyel; László Dézsi; Péter Biliczki; Csilla Horváth; László Virág; Norbert Iost; Miklós Németh; László Tálosi; Julius Gy Papp; András Varró
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

9.  Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.

Authors:  Guilda Sarraf; Terrance D Barrett; Michael J A Walker
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs.

Authors:  Orsolya Nagy; Agnes Hajnal; James R Parratt; Agnes Végh
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

View more
  4 in total

Review 1.  Pilsicainide.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

2.  Overexpression of M₃ muscarinic receptor is a novel strategy for preventing sudden cardiac death in transgenic mice.

Authors:  Yan Liu; Lihua Sun; Zhenwei Pan; Yunlong Bai; Ning Wang; Jinlong Zhao; Chaoqian Xu; Zhi Li; Baoxin Li; Zhimin Du; Yanjie Lu; Xu Gao; Baofeng Yang
Journal:  Mol Med       Date:  2011-07-13       Impact factor: 6.354

3.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 4.  Neurological perspectives on voltage-gated sodium channels.

Authors:  Niels Eijkelkamp; John E Linley; Mark D Baker; Michael S Minett; Roman Cregg; Robert Werdehausen; François Rugiero; John N Wood
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.